0001209191-23-024228.txt : 20230413
0001209191-23-024228.hdr.sgml : 20230413
20230413171418
ACCESSION NUMBER: 0001209191-23-024228
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20230413
FILED AS OF DATE: 20230413
DATE AS OF CHANGE: 20230413
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Lian Brian
CENTRAL INDEX KEY: 0001614578
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-37355
FILM NUMBER: 23819118
MAIL ADDRESS:
STREET 1: C/O SEELOS THERAPEUTICS, INC.
STREET 2: 300 PARK AVENUE, 12TH FLOOR
CITY: NEW YORK
STATE: NY
ZIP: 10022
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Viking Therapeutics, Inc.
CENTRAL INDEX KEY: 0001607678
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 461073877
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 9920 PACIFIC HEIGHTS BLVD, SUITE 350
CITY: SAN DIEGO
STATE: CA
ZIP: 92121
BUSINESS PHONE: 858-704-4660
MAIL ADDRESS:
STREET 1: 9920 PACIFIC HEIGHTS BLVD, SUITE 350
CITY: SAN DIEGO
STATE: CA
ZIP: 92121
4
1
doc4.xml
FORM 4 SUBMISSION
X0407
4
2023-04-13
0
0001607678
Viking Therapeutics, Inc.
VKTX
0001614578
Lian Brian
C/O VIKING THERAPEUTICS, INC.
9920 PACIFIC HEIGHTS BLVD, SUITE 350
SAN DIEGO
CA
92121
1
1
0
0
President & CEO
0
Common Stock, par value $0.00001 per share
2023-04-13
4
M
0
54336
1.88
A
2387299
D
Common Stock, par value $0.00001 per share
2023-04-13
4
S
0
79336
18.45
D
2307963
D
Stock Option (right to buy)
1.88
2023-04-13
4
M
0
54336
0.00
D
2016-03-14
2026-03-14
Common Stock
54336
0
D
The transactions reported in this Form 4 were effected pursuant to a Rule10b5-1 trading plan adopted by the Reporting Person
/s/ Michael Morneau, as Attorney-in-Fact
2023-04-13